News We’re Watching: New FDA Guidance on DHTs and COVID-19 Antibodies, Device Shortage List Updated, Philips False Claims Case Settled
Executive Summary
This week, the US FDA released guidance documents on COVID-19 monoclonal antibodies and the use of digital health technologies in remote trials; Philips’ Biotelemetry pays $14.7m to settle False Claims Act allegations; recalls of bronchoscopes, tracheostomy trays and software; and more.